Rani Therapeutics to Participate in a Fireside Chat at the Stifel 2021 Virtual Healthcare Conference
Rani Therapeutics (NASDAQ: RANI) announced that CEO Talat Imran will participate in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on November 17, 2021, at 7:00 a.m. PT / 10:00 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Rani Therapeutics (NASDAQ: RANI) announced that CEO Talat Imran will participate in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on November 17, 2021, at 7:00 a.m. PT / 10:00 a.m. ET. The event will focus on the company’s innovative oral delivery system for biologics, utilizing the proprietary RaniPill™ capsule. Interested parties can access the live audio webcast through the company's website. A replay will be available for 30 days.
Details
News Market Reaction – RANI
The recorded move for RANI in the trading session of this news was +6.68%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN JOSE, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Rani Therapeutics (NASDAQ: RANI), a clinical stage biotherapeutics company focused on the oral delivery of biologics, today announced that the company’s Chief Executive Officer, Talat Imran, will participate in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on Wednesday, November 17, 2021, at 7:00 a.m. PT / 10:00 a.m. ET.
Interested parties can access the live audio webcast for this conference from the Investor Relations section of the company's website at www.ranitherapeutics.com. The webcast replay will be available after the conclusion of the live presentation for approximately 30 days.
About Rani Therapeutics
Rani Therapeutics is a clinical stage biotherapeutics company focused on the oral delivery of biologics, which we believe will have the potential to transform medicine and improve patient outcomes. The company has developed the RaniPill™ capsule, a novel, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using the RaniPill™ capsule.
Investor Contact:
investors@ranitherapeutics.com
Media Contact:
media@ranitherapeutics.com
Source: Rani Therapeutics
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.